Dr. Vandross is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
805 west 37th
Austin, TX 78705
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2014 - 2017
Yale-New Haven Medical CenterResidency, Internal Medicine, 2011 - 2014- Yale-New Haven Medical CenterResidency, Surgery, 2009 - 2011
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2009
Certifications & Licensure
TX State Medical License 2020 - 2026
CA State Medical License 2014 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 263 citationsThe Strength of Association Between Surrogate End Points and Survival in Oncology: A Systematic Review of Trial-Level Meta-analysesVinay Prasad, Chul Kim, Mauricio Burotto, Andrae Vandross
JAMA Internal Medicine. 2015-08-01 - 231 citationsA Decade of Reversal: An Analysis of 146 Contradicted Medical PracticesVinay Prasad, Andrae Vandross, Caitlin Toomey, Michael Cheung, Jason Rho
Mayo Clinic Proceedings. 2013-08-01 - 3 citationsASCO Plenary Sessions: impact, legacy, futureAndrae Vandross, Vinay Prasad, Sham Mailankody
Seminars in Oncology. 2016-06-01
Press Mentions
Chemo-IO over IO Alone in Patients with Advanced NSCLCJuly 13th, 2021- Genomic Test in Lung Cancer: Waiting Is the Hardest PartJuly 6th, 2021
- What the New KRAS Inhibitor Means for Lung CancerJune 29th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
